Biocon Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Biocon Ltd.

Biocon Ltd. | Mutual Funds

Mutual Funds that own Biocon Ltd.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Oppenheimer Developing Markets Fund

25,845,152

4.3%

10,350,788

0.62%

02/28/2018

Jupiter India Fund

6,828,220

1.13%

-453,299

4.86%

02/28/2018

Birla Sun Life Tax Relief '96

2,722,029

0.45%

28,274

2.48%

07/31/2018

Reliance Pharma Fund

2,403,889

0.4%

5.72%

08/31/2018

ICICI Prudential Focused Bluechip Equity Fund

2,382,447

0.4%

0.74%

08/31/2018

Templeton Developing Markets Trust

2,381,186

0.4%

1.42%

03/31/2018

Vanguard Emerging Markets Stock Index Fund

2,351,151

0.39%

-17,150

0.03%

07/31/2018

GS Funds - India Equity Portfolio

2,182,629

0.36%

0.74%

06/30/2018

Kotak Equity Arbitrage Fund

2,052,900

0.34%

-75,600

0.45%

07/31/2018

Vanguard Total International Stock Index Fund

2,037,390

0.34%

0.01%

07/31/2018

About Biocon

View Profile

Address	20th KM, Hosur Road Bangalore Karnataka 560100 India
Employees	-
Website	http://www.biocon.com
Updated	09/14/2018
Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc.